Antibiotics Market

Best Price Guarantee	Publisher	Published Date	SKU
from $3,475	Evolve Business Intelligence	April, 2025	EVBI19932168

Best Price Guarantee
Price	from $3,475
Publisher	Evolve Business Intelligence
Published Date	April, 2025
SKU	EVBI19932168

The Antibiotics Market is projected to reach USD 41.65 billion by 2033, up from USD 32.54 billion in 2023, with an anticipated compound annual growth rate (CAGR) of 1.65% from 2023 to 2033. This market encompasses the global demand for pharmaceutical products aimed at treating bacterial infections, including a variety of antibacterial drugs such as penicillins, cephalosporins, macrolides, fluoroquinolones, and tetracyclines. The increasing prevalence of infectious diseases and the need for effective treatments are key drivers of market growth. Broad-spectrum antibiotics, such as amoxicillin and levofloxacin, play a particularly significant role. Additionally, the market is expected to grow at a CAGR of 5.67% from 2023 to 2028, driven by factors such as heightened awareness of disease detection and treatment, favorable regulatory designations, and ongoing clinical trials aimed at combating antibiotic resistance.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Class (Beta Lactam & Beta Lactamase Inhibitors, Quinolone, Macrolide, Others)
By Drug Origin (Natural, Semisynthetic, Synthetic)
By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic)

Key players

Abbott Laboratories
Allergan Plc
HOFFMANN-LA ROCHE LTD.
GlaxoSmithKline Plc
Merck & Co. Inc
Mylan N.V
Novartis International AG
Pfizer Inc
Teva Pharmaceutical Industries Ltd.
Sanofi

CHAPTER 1. Executive Summary: CHAPTER 2. Scope of the Study; 2.1. Market Definition; 2.2. Market Scope & Segmentation; 2.2.1. Objective of Report; CHAPTER 3. Evolve BI Methodology; 3.1. Data Collection & Validation Approach; 3.2. Market Size Estimation and Forecast; CHAPTER 4. Exclusive Analysis; 4.1. Market Opportunity Score; 4.1.1. Class Segement – Market Opportunity Score; 4.1.2. Drug Origin Segment – Market Opportunity Score; 4.1.3. Spectrum of Activity Segment – Market Opportunity Score; 4.2. Key Market Influencing Indicators; CHAPTER 5. Market Insights and Trends; 5.1. Value Chain Analysis; 5.1.1. Raw Material; 5.1.2. Manufacturing Process; 5.1.3. Distribution Channel; 5.1.4. End User; 5.2. Porter’s Five Forces Analysis; 5.2.1. Bargaining Power of Buyers; 5.2.2. Bargaining Power of Suppliers; 5.2.3. Threat of New Entrant; 5.2.4. Threat of Substitute; 5.2.5. Industry Rivalry; 5.3. COVID-19 Impact and Post COVID Scenario on Antibiotics Market; 5.3.1. Impact of COVID-19; 5.3.2. Government Support and Industry Revival Policies; 5.3.3. Measures Taken by Companies to Mitigate Negative Impact; 5.3.4. Post COVID Trend; CHAPTER 6. MArket Dynamics; 6.1. Introduction; 6.2. Drivers; 6.2.1. Driver 1; 6.2.2. Driver 2; 6.2.3. Driver 3; 6.3. Restraints; 6.3.1. Restraint 1; 6.3.2. Restraint 2; 6.4. Opportunity; 6.4.1. Opportunity 1; CHAPTER 7. Global Antibiotics Market, By Class; 7.1. Introduction; 7.1.1. Beta Lactam & Beta Lactamase Inhibitors; 7.1.2. Quinolone; 7.1.3. Macrolide; 7.1.4. Others; CHAPTER 8. Global Antibiotics Market, By Drug Origin; 8.1. Introduction; 8.1..1. Natural; 8.1.2. Semisynthetic; 8.1.3. Synthetic; 8.1.4. Drug Origin; CHAPTER 9. Global Antibiotics Market, By Spectrum of Activity; 9.1. Introduction; 9.1.1. Broad-spectrum Antibiotic; 9.1.2. Narrow-spectrum Antibiotic; CHAPTER 10. Global Antibiotics Market, By Region; 10.1. Introduction; 10.2. NORTH AMERICA; 10.2.1. North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.2.2. North America: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.2.3. North America: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.2.4. North America: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.2.5. US; 10.2.5.1. US: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.2.5.2. US: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.2.5.3. US: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.2.6. CANADA; 10.2.6.1. Canada: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.2.6.2. Canada: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.2.6.3. Canada: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.2.7. MEXICO; 10.2.7.1. Mexico: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.2.7.2. Mexico: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.2.7.3. Mexico: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.3. Europe; 10.3.1. Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.3.2. Europe: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.3.3. Europe: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.3.4. Europe: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.3.5. U.K.; 10.3.5.1. U.K.: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.3.5.2. U.K.: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.3.5.3. U.K.: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.3.6. GERMANY; 10.3.6.1. Germany: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.3.6.2. Germany: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.3.6.3. Germany: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.3.7. FRANCE; 10.3.7.1. France: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.3.7.2. France: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.3.7.3. France: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.3.8. ITALY; 10.3.8.1. Italy: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.3.8.2. Italy: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.3.8.3. Italy: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.3.9. SPAIN; 10.3.9.1. Spain: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.3.9.2. Spain: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.3.9.3. Spain: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.3.10. BENELUX; 10.3.10.1. BeNeLux: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.3.10.2. BeNeLux: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.3.10.3. BeNeLux: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.3.11. RUSSIA; 10.3.11.1. Russia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.3.11.2. Russia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.3.11.3. Russia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.3.12. REST OF EUROPE; 10.3.12.1. Rest of Europe: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.3.12.2. Rest of Europe: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.3.12.3. Rest of Europe: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4. Asia Pacific; 10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.4.2. Asia Pacific: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.3. Asia Pacific: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.4. Asia Pacific: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4.5. CHINA; 10.4.5.1. China: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.5.2. China: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.5.3. China: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4.6. JAPAN; 10.4.6.1. Japan: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.6.2. Japan: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.6.3. Japan: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4.7. INDIA; 10.4.7.1. India: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.7.2. India: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.7.3. India: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4.8. SOUTH KOREA; 10.4.8.1. South Korea: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.8.2. South Korea: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.8.3. South Korea: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4.9. THAILAND; 10.4.9.1. Thailand: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.9.2. Thailand: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.9.3. Thailand: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4.10. INDONESIA; 10.4.10.1. Indonesia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.10.2. Indonesia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.10.3. Indonesia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4.11. MALAYSIA; 10.4.11.1. Malaysia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.11.2. Malaysia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.11.3. Malaysia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4.12. AUSTRALIA; 10.4.12.1. Australia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.12.2. Australia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.12.3. Australia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.4.13. REST FO ASIA PACIFIC; 10.4.13.1. Rest fo Asia Pacific: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.4.13.2. Rest fo Asia Pacific: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.4.13.3. Rest fo Asia Pacific: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.5. South America; 10.5.1. South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.5.2. South America: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.5.3. South America: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.5.4. South America: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.5.5. BRAZIL; 10.5.5.1. Brazil: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.5.5.2. Brazil: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.5.5.3. Brazil: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.5.6. ARGENTINA; 10.5.6.1. Argentina: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.5.6.2. Argentina: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.5.6.3. Argentina: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.5.7. REST OF SOUTH AMERICA; 10.5.7.1. Rest of South America: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.5.7.2. Rest of South America: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.5.7.3. Rest of South America: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.6. Middle East & Africa; 10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.6.2. Middle East & Africa: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.6.3. Middle East & Africa: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.6.4. Middle East & Africa: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.6.5. SAUDI ARABIA; 10.6.5.1. Saudi Arabia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.6.5.2. Saudi Arabia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.6.5.3. Saudi Arabia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.6.6. UAE; 10.6.6.1. UAE: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.6.6.2. UAE: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.6.6.3. UAE: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.6.7. EGYPT; 10.6.7.1. Egypt: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.6.7.2. Egypt: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.6.7.3. Egypt: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.6.8. SOUTH AFRICA; 10.6.8.1. South Africa: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.6.8.2. South Africa: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.6.8.3. South Africa: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); 10.6.9. REST OF MIDDLE EAST & AFRICA; 10.6.9.1. Rest of Middle East & Africa: Market Size and Forecast, By Class, 2023 – 2033 ($ Million); 10.6.9.2. Rest of Middle East & Africa: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million); 10.6.9.3. Rest of Middle East & Africa: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million); CHAPTER 12. Competitive Landscape; 12.1. Competitior Benchmarking 2023; 12.2. Market Share Analysis; 12.3. Key Developments Analysis By Top 5 Companies; 12.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players; CHAPTER 13. Company Profiles; 13.1. Abbott Laboratories; 13.1.1. Business Overview; 13.1.2. Financial Analysis; 13.1.2.1. Business Segment Revenue, 2020, 2021, 2022, $ Million; 13.1.2.2. Geographic Revenue Mix, 2022 (% Share); 13.1.3. Product Portfolio; 13.1.4. Recent Development and Strategies Adopted; 13.1.5. SWOT Analysis; 13.2. Allergan Plc; 13.3. HOFFMANN-LA ROCHE LTD.; 13.4. GlaxoSmithKline Plc; 13.5. Merck & Co. Inc; 13.6. Mylan N.V; 13.7. Novartis International AG; 13.8. Pfizer Inc; 13.9. Teva Pharmaceutical Industries Ltd.; 13.10. Sanofi